Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page
- Check2 days agoChange Detected- The page metadata now shows Revision: v3.5.2; the previous label v3.5.0 has been removed.SummaryDifference0.0%

- Check9 days agoChange DetectedPadova, Italy, 35128 was added and Padua, Italy, 35128 was removed from the study locations.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Naples, Italy, 20133 to the Locations list and removed Napoli, Italy, 20133.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision: v3.5.0 has been published, replacing the prior revision v3.4.3.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision: v3.4.3 implemented, replacing v3.4.2.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This reflects a routine version update in the site's revision history.SummaryDifference0.0%

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.